mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0002 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0002 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0002 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0002 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0002 |
mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0002 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
0.0002 |